Coronavirus Vaccine Trial

Coronavirus Vaccine Trial

  • World

    Japan's Fujifilm begins clinical trials to test its anti-flu drug that promises to treat coronavirus

    Tokyo: Japan's Fujifilm has begun clinical trials to test the effectiveness of its anti-flu drug Avigan in treating patients with the new coronavirus, after reports of promising results in China.Trials in China have suggested Avigan could play a role in shortening the recovery time for patients infected with coronavirus.

    • 2 days ago
  • Science

    Japan gives the go-ahead to test Fujifilm's anti-flu drug Avigan in fight against coronavirus

    Trials in China have suggested Avigan could play a role in shortening the recovery time for patients infected with coronavirus. Tokyo: Japan's Fujifilm has begun clinical trials to test the effectiveness of its anti-flu drug Avigan in treating patients with the new coronavirus, after reports of promising results in China. "The trial will be...

    • 2 days ago
  • Corona Delhi

    Covid-19 update: Jawaharlal Nehru Stadium to serve as quarantine facility

    The Jawaharlal Nehru Stadium at the heart of the national capital here is being transformed into a quarantine facility in the wake of the Covid-19 pandemic. The order to take over the stadium from the Sports Authority of India was sent on Monday by Harleen Kaur, District Magistrate, Chairperson DDMA of South East Delhi. '..it has been considered necessary to requisite...

    • 3 days ago
  • Latest

    Johnson & Johnson will soon begin COVID-19 vaccine trials

    Johnson & Johnson has announced it has selected the lead vaccine candidate for the novel coronavirus disease COVID-19. The healthcare company says that the experimental vaccine is expected to go into human trials by September 2020 and might become available for emergency use by early next year.

    • 3 days ago
  • Science

    Human trials of Johnson & Johnson coronavirus vaccine to begin in September

    US pharmaceutical Moderna has already moved into human trials for its vaccine candidate, as has China's CanSinoBIO. Washington: Johnson & Johnson has said it had selected a lead candidate vaccine for the new coronavirus that would move to human trials by September and could be ready for emergency use by early next year. The pharmaceutical company has signed an...

    • 3 days ago
  • Science and Trends

    Johnson & Johnson to begin coronavirus vaccine trials on humans in September

    Washington: Johnson & Johnson has said it had selected a lead candidate vaccine for the new coronavirus that would move to human trials by September and could be ready for emergency use by early next year. The pharmaceutical company has signed an agreement with the US government's Biomedical Advanced Research and Development Authority to invest USD 1 billion in the...

    • 3 days ago
  • Home

    Johnson & Johnson Stocks Jump 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September

    Johnson & Johnson stocks climbed 8% on Monday after the company announced its plan to begin human trials of vaccine for the new coronavirus by September and said that it could be ready for emergency use by early next year. The pharmaceutical company has signed an agreement with the US government's Biomedical Advanced Research and Development...

    • 3 days ago
  • Home

    Johnson & Johnson to start human trial of COVID-19 vaccine by September

    US-based global healthcare company Johnson & Johnson on Monday announced the selection of a lead COVID-19 vaccine candidate, adding that it expects to initiate testing of the vaccine in humans at the latest by September this year.The first batches of a COVID-19 vaccine could be available for emergency use authorisation in early 2021, the company said.Through a landmark...

    • 3 days ago
  • Corona Virus

    Johnson & Johnson to conduct human trials for COVID-19 vaccine by Sept

    Popular pharmaceutical company Johnson & Johnson on Monday said it has selected a lead candidate vaccine for COVID-19 which would be used for human trials in September and be ready for emergency use by early next year. The pharmaceutical company in partnership with the US Department of Health and Human Services has invested more than $1 billion for carrying out the...

    • 3 days ago
  • Latest

    Johnson & Johnson expects to start human testing of COVID-19 vaccine by September

    New Delhi, Mar 31: Global healthcare major Johnson & Johnson (J&J) said it expects to start human testing of its COVID-19 vaccine by September 2020 and anticipates that the first batch of vaccine could be available for emergency use authorisation in early 2021. Through a partnership, the Biomedical Advanced Research and Development Authority (BARDA) and...

    • 3 days ago

Loading...

Top